Randomized phase 2 trial of cediranib alone or cediranib plus lenalidomide in iodine 131-refractory differentiated thyroid cancer (DTC): A University of Chicago Phase 2 Consortium trial.

Jonas A. De Souza; Theodore Karrison; Bernadette Libao; Francis P. Worden; Monika Krzyzanowska; David N. Hayes; Eric Winquist; Vassiliki Saloura; Victoria Meucci Villaflor; Tanguy Y. Seiwert; Walter Michael Stadler; Ezra E.W. Cohen; Rebecca B. Schechter; Everett E. Vokes

doi:10.1200/jco.2016.34.15_suppl.6013

Randomized phase 2 trial of cediranib alone or cediranib plus lenalidomide in iodine 131-refractory differentiated thyroid cancer (DTC): A University of Chicago Phase 2 Consortium trial.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.6013 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 6013-6013 ◽

Cited By ~ 1

Author(s):

Jonas A. De Souza ◽

Theodore Karrison ◽

Bernadette Libao ◽

Francis P. Worden ◽

Monika Krzyzanowska ◽

...

Keyword(s):

Thyroid Cancer ◽

Differentiated Thyroid Cancer ◽

Phase 2 ◽

University Of Chicago ◽

Phase 2 Trial ◽

Iodine 131 ◽

Randomized Phase 2

Download Full-text

Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial

The Lancet Oncology ◽

10.1016/s1470-2045(12)70335-2 ◽

2012 ◽

Vol 13 (9) ◽

pp. 897-905 ◽

Cited By ~ 212

Author(s):

Sophie Leboulleux ◽

Lars Bastholt ◽

Thomas Krause ◽

Christelle de la Fouchardiere ◽

Jan Tennvall ◽

...

Keyword(s):

Thyroid Cancer ◽

Differentiated Thyroid Cancer ◽

Locally Advanced ◽

Phase 2 ◽

Double Blind ◽

Phase 2 Trial

Download Full-text

A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine‐refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment

Cancer ◽

10.1002/cncr.29395 ◽

2015 ◽

Vol 121 (16) ◽

pp. 2749-2756 ◽

Cited By ~ 90

Author(s):

Maria E. Cabanillas ◽

Martin Schlumberger ◽

Barbara Jarzab ◽

Renato G. Martins ◽

Furio Pacini ◽

...

Keyword(s):

Thyroid Cancer ◽

Clinical Outcomes ◽

Differentiated Thyroid Cancer ◽

Phase 2 ◽

Phase 2 Trial

Download Full-text

Faculty Opinions recommendation of A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717953610.793459214 ◽

2012 ◽

Author(s):

John H Lazarus

Keyword(s):

Thyroid Cancer ◽

Anaplastic Thyroid Cancer ◽

Phase 2 ◽

Phase 2 Trial

Download Full-text

A randomized phase 2 trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma

Acta Oncologica ◽

10.1080/0284186x.2021.1928281 ◽

2021 ◽

pp. 1-6

Author(s):

Peter C. Petersen ◽

Lone N. Petersen ◽

Ivan Vogelius ◽

Jon K. Bjerregaard ◽

Lene Baeksgaard

Keyword(s):

Phase 2 ◽

First Line ◽

Phase 2 Trial ◽

Randomized Phase 2 ◽

Esophagogastric Adenocarcinoma

Download Full-text

Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial

Oral Oncology ◽

10.1016/j.oraloncology.2021.105192 ◽

2021 ◽

Vol 115 ◽

pp. 105192

Author(s):

Douglas R. Adkins ◽

Jin-Ching Lin ◽

Assuntina Sacco ◽

Jessica Ley ◽

Peter Oppelt ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Human Papillomavirus ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Neck Squamous Cell Carcinoma ◽

Phase 2 ◽

Double Blind ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

P76.24 A Randomized Phase 2 Trial of Anlotinib Plus Docetaxel vs Docetaxel as 2nd-Line Therapy for EGFR-Negative NSCLC (ALTER-L018)

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.1081 ◽

2021 ◽

Vol 16 (3) ◽

pp. S596

Author(s):

L. Wu ◽

Z. Wu ◽

Z. Xiao ◽

J. Weng ◽

M. Xiao ◽

...

Keyword(s):

Phase 2 ◽

Phase 2 Trial ◽

Line Therapy ◽

Randomized Phase 2

Download Full-text

Seven Days Treatment With the Angiotensin II Type 2 Receptor Agonist C21 in Hospitalized COVID-19 Patients: A Placebo-Controlled Randomized Phase 2 Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3889369 ◽

2021 ◽

Author(s):

Göran Tornling ◽

Rohit Batta ◽

Joanna C. Porter ◽

Bryan Williams ◽

Thomas Bengtsson ◽

...

Keyword(s):

Angiotensin Ii ◽

Receptor Agonist ◽

Phase 2 ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

Durvalumab, Tremelimumab Alone or in Combination With Low-Dose or Hypofractionated Targeted Radiotherapy in Metastatic Non-Small Cell Lung Cancer Refractory to Prior PD-1 Therapy: A Multicentre, Open-Label, Randomized, Phase 2 Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3922682 ◽

2021 ◽

Author(s):

Jonathan D. Schoenfeld ◽

Anita Giobbie-Hurder ◽

Srinika Ranasinghe ◽

Katrina Z. Kao ◽

Ana Lako ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Low Dose ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Open Label ◽

Targeted Radiotherapy ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

Abstract PD1-06: Trilaciclib improves overall survival when given with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: Final analysis of a randomized phase 2 trial

10.1158/1538-7445.sabcs20-pd1-06 ◽

2021 ◽

Author(s):

Joyce O'Shaughnessy ◽

Gail S Wright ◽

Anu R Thummala ◽

Michael A Danso ◽

Lazar Popovic ◽

...

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Final Analysis ◽

Phase 2 ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

A Multi-Institutional Randomized Phase 2 Trial of the Oncolytic Virus Reolysin in the First Line Treatment Metastatic Adenocarcinoma of the Pancreas (Map)

Annals of Oncology ◽

10.1093/annonc/mdu438.19 ◽

2014 ◽

Vol 25 ◽

pp. v1 ◽

Cited By ~ 5

Author(s):

T. Bekaii-Saab ◽

A.M. Noonan ◽

G. Lesinski ◽

S. Mikhail ◽

K. Ciombor ◽

...

Keyword(s):

Oncolytic Virus ◽

Line Treatment ◽

Metastatic Adenocarcinoma ◽

Phase 2 ◽

First Line ◽

Phase 2 Trial ◽

Adenocarcinoma Of The Pancreas ◽

Randomized Phase 2 ◽

First Line Treatment

Download Full-text